- Home
- CLIK vs HCWB Comparison
CLIK vs HCWB Comparison
Compare CLIK & HCWB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLIK
- HCWB
- Stock Information
- Founded
- CLIK 2017
- HCWB 2018
- Country
- CLIK Hong Kong
- HCWB United States
- Employees
- CLIK N/A
- HCWB N/A
- Industry
- CLIK
- HCWB Biotechnology: Pharmaceutical Preparations
- Sector
- CLIK
- HCWB Health Care
- Exchange
- CLIK NYSE
- HCWB Nasdaq
- Market Cap
- CLIK 24.6M
- HCWB 26.6M
- IPO Year
- CLIK 2024
- HCWB 2021
- Fundamental
- Price
- CLIK $1.24
- HCWB $0.40
- Analyst Decision
- CLIK
- HCWB
- Analyst Count
- CLIK 0
- HCWB 0
- Target Price
- CLIK N/A
- HCWB N/A
- AVG Volume (30 Days)
- CLIK 106.4K
- HCWB 652.7K
- Earning Date
- CLIK 02-14-2025
- HCWB 11-14-2024
- Dividend Yield
- CLIK N/A
- HCWB N/A
- EPS Growth
- CLIK N/A
- HCWB N/A
- EPS
- CLIK 0.06
- HCWB N/A
- Revenue
- CLIK $5,657,132.00
- HCWB $3,495,990.00
- Revenue This Year
- CLIK N/A
- HCWB $229.19
- Revenue Next Year
- CLIK N/A
- HCWB N/A
- P/E Ratio
- CLIK $20.89
- HCWB N/A
- Revenue Growth
- CLIK 36.12
- HCWB 22.27
- 52 Week Low
- CLIK $1.15
- HCWB $0.28
- 52 Week High
- CLIK $4.39
- HCWB $2.52
- Technical
- Relative Strength Index (RSI)
- CLIK N/A
- HCWB 45.86
- Support Level
- CLIK N/A
- HCWB $0.32
- Resistance Level
- CLIK N/A
- HCWB $0.45
- Average True Range (ATR)
- CLIK 0.00
- HCWB 0.05
- MACD
- CLIK 0.00
- HCWB 0.00
- Stochastic Oscillator
- CLIK 0.00
- HCWB 59.36
About CLIK CLICK HOLDINGS LIMITED
Click Holdings Ltd is a human resources solutions provider, specializing in offering comprehensive human resources solutions. It is focused on talent sourcing and the provision of temporary and permanent personnel to customers and also in placing professional accountants and company secretaries, registered nurses and healthcare workers as well as other blue-collar workers, for direct hire and contract staffing roles. The Company operates in three segments, 1) professional solution services, 2) nursing solution services and 3) logistic and other solution services. Maximum revenue is generated from Professional solution services and Hong Kong.
About HCWB HCW Biologics Inc.
HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.